Home › Targets › MC4R
MC4R (2 companies · 21 programs)
Companies with an active program directed at MC4R.
- IMCIVREE — Bardet-Biedl Syndrome Approved
- IMCIVREE — POMC Deficiency Obesity Approved
- IMCIVREE — LEPR Deficiency Obesity Approved
- IMCIVREE — Acquired Hypothalamic Obesity Approved
- IMCIVREE — Congenital Hypothalamic Obesity Phase 3
- IMCIVREE — Prader-Willi Syndrome Phase 2
- IMCIVREE — POMC Insufficiency Obesity Phase 3
- IMCIVREE — LEPR Insufficiency Obesity Phase 3
- IMCIVREE — SRC1 Deficiency Obesity Phase 3
- IMCIVREE — SH2B1 Deficiency Obesity Phase 3
- bivamelagon — Acquired Hypothalamic Obesity Phase 2
- RM-718 — Acquired Hypothalamic Obesity Phase 1
- RM-718 — Prader-Willi Syndrome Phase 1
- bremelanotide — Obesity Phase 2
- bremelanotide — Erectile Dysfunction
- PL9643 — Dry Eye Disease Phase 3
- PL8177 — Ulcerative Colitis Phase 2
- PL7737 — Obesity Preclinical
- PL7737 — Hypothalamic Obesity
- PL7737 Preclinical
- PL7737 — Prader-Willi Syndrome
